小鼠内毒素性与人类脓毒性休克中的醛固酮与血管盐皮质激素受体
本研究为实验研究,含小鼠内毒素性休克模型与人类血管细胞及脓毒症患者血浆体外实验。小鼠注射脂多糖和/或醛固酮;人内皮与平滑肌细胞用促炎细胞因子、BAY 11-7082或脓毒症患者血浆处理。结果显示醛固酮改善小鼠内毒素性休克诱导后18小时的有创动脉压、体内及离体动脉对去氧肾上腺素的反应,并提高5天生存率;小鼠主动脉α1肾上腺素受体与盐皮质激素受体表达在内毒素血症6和18小时下调、醛固酮治疗组恢复。肿瘤坏死因子-α经核因子-κB通路依赖方式5小时内降低人血管细胞盐皮质激素受体与α1肾上腺素受体表达;脓毒症患者血浆处理的人细胞盐皮质激素受体表达亦减弱。作者认为盐皮质激素的有益效应与α1肾上腺素受体表达恢复相关,血管盐皮质激素受体表达减弱可能参与脓毒症血流动力学衰竭。
要点
- 小鼠内毒素性休克模型中,醛固酮改善5天生存率、有创动脉压及18小时体内与离体动脉对去氧肾上腺素的反应性。
- 内毒素血症小鼠主动脉α1肾上腺素受体与盐皮质激素受体表达在6和18小时下调,醛固酮治疗组恢复。
- 肿瘤坏死因子-α经核因子-κB通路依赖方式在5小时内降低人血管细胞盐皮质激素受体与α1肾上腺素受体表达。
- 脓毒症患者血浆处理的人血管细胞盐皮质激素受体表达减弱。
- 作者认为血管盐皮质激素受体表达减弱可能参与脓毒症血流动力学衰竭。
适用人群与场景
- 成年雄性C57Black 6小鼠,内毒素性休克模型
- 成年脓毒性休克患者(提供血浆用于体外实验)
处置流程与药物剂量
- 小鼠注射脂多糖和/或醛固酮(原文未写明醛固酮剂量、给药途径与频次)
- 人内皮与平滑肌细胞用促炎细胞因子处理,加或不加醛固酮、核因子-κB抑制剂BAY 11-7082,或用脓毒症患者血浆处理
研究设计与关键结果
- 实验研究,含小鼠内毒素性休克模型与人类血管细胞及脓毒症患者血浆体外实验。
- 醛固酮改善小鼠内毒素性休克诱导后5天生存率、有创动脉压及18小时体内与离体动脉对去氧肾上腺素的反应性。
- 小鼠主动脉α1肾上腺素受体与盐皮质激素受体表达在内毒素血症6和18小时下调,醛固酮治疗组恢复。
- 肿瘤坏死因子-α经核因子-κB通路依赖方式在5小时内降低人血管细胞盐皮质激素受体与α1肾上腺素受体表达。
- 脓毒症患者血浆处理的人血管细胞盐皮质激素受体表达减弱。
证据类型、等级与局限
- 证据类型:实验研究(动物实验与体外实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为盐皮质激素对生存、血压和血管反应性有益,并与内毒素性休克中α1肾上腺素受体表达恢复相关。
- 作者认为血管盐皮质激素受体表达减弱可能参与脓毒症血流动力学衰竭。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Vascular mineralocorticoid receptors play a role in vascular tone and blood pressure regulation, might participate in the pathophysiology of circulatory failure during sepsis, and represent a potential therapeutic target in this disease. We aimed to study the effects of mineralocorticoids and the involvement of vascular mineralocorticoid receptors in murine endotoxic and human septic shock.
DESIGN: Experimental study.
SETTING: Translational investigation including animal research and in vitro experiments using human vascular cells and plasma from septic patients.
SUBJECTS: Adult male C57Black 6 mice, adult patients with septic shock.
INTERVENTIONS: Mice were injected with lipopolysaccharide and/or aldosterone. Human endothelial and smooth muscle cells were treated with pro-inflammatory cytokines with or without aldosterone, nuclear factor-κB inhibitor BAY 11-7082, or plasma from septic patients.
MEASUREMENTS AND MAIN RESULTS: Aldosterone improved 5-day survival, invasive arterial pressure, and in vivo and ex vivo arterial response to phenylephrine at 18 hours after induction of murine endotoxic shock. Both α1-adrenoceptor and mineralocorticoid receptor expressions studied in mouse aortas were down-regulated at 6 and 18 hours in endotoxemic mice and restored in aldosterone-treated mice. Furthermore, tumor necrosis factor-α decreased both mineralocorticoid receptor and α1-adrenoceptor expressions within 5 hours in human vascular cells in a nuclear factor-κB pathway-dependent manner. Mineralocorticoid receptor expression was also blunted in human cells treated with plasma from septic patients.
CONCLUSION: We found a beneficial effect of mineralocorticoids on survival, blood pressure, and vascular reactivity, associated with a restoration of α1-adrenoceptor expression in endotoxic shock. Furthermore, blunted vascular mineralocorticoid receptor expression might participate in hemodynamic failure during sepsis.
参考来源
- Fadel F, André-Grégoire G, Gravez B, et al. Aldosterone and Vascular Mineralocorticoid Receptors in Murine Endotoxic and Human Septic Shock. Crit Care Med. 2017. PMID: 28445239. doi:10.1097/CCM.0000000000002462
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。